Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Circulation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9521340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombospondin modulates alpha v beta 3 function through integrin- associated protein

  1996cited by this paper
• Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.

  1996cited by this paper
• cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells.

  1995cited by this paper
• Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1

  1995cited by this paper
• Alpha-v beta-3 integrin expression in normal and atherosclerotic artery.

  1995cited by this paper
• Integrins and signal transduction pathways: the road taken.

  1995cited by this paper
• The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.

  1995cited by this paper
• Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. A process facilitated by cell-surface proteoglycans.

  1995cited by this paper
• A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.

  1995cited by this paper
• Integrin transmembrane signaling and cytoskeletal control.

  1995cited by this paper
• Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA.

  1994cited by this paper
• Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes.

  1994cited by this paper
• TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms.

  1994cited by this paper
• Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK

  1994cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

  1994cited by this paper
• Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis.

  1994cited by this paper
• Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin.

  1994cited by this paper
• Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.

  1994cited by this paper
• Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth.

  1993cited by this paper
• Thrombospondin mediates migration and potentiates platelet‐derived growth factor‐dependent migration of calf pulmonary artery smooth muscle cells

  1993cited by this paper
• Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty A Multicenter Randomized Double‐Blind Placebo‐Controlled Trial

  1993cited by this paper
• Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells.

  1992cited by this paper
• Regulation of vascular smooth muscle cell integrin expression by transforming growth factor β1 and by platelet‐derived growth factor‐BB

  1992cited by this paper
• Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.

  1992cited by this paper
• Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).

  1991cited by this paper
• Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF

  1991cited by this paper
• A large accumulation of non-muscle myosin occurs at first entry into M phase in rat vascular smooth-muscle cells.

  1991cited by this paper
• Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

  1991cited by this paper
• Effectiveness of Recombinant Desulphatohirudin in Reducing Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits

  1991cited by this paper
• Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty.

  1990cited by this paper
• Thrombospondin deposition in rat carotid artery injury.

  1990cited by this paper
• Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors.

  1989cited by this paper
• Signal transduction by the platelet-derived growth factor receptor.

  1989cited by this paper
• Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors

  1988cited by this paper
• Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

  1988cited by this paper
• Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells

  1988cited by this paper
• Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor.

  1987cited by this paper
• Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

  1986cited by this paper
• Light microscopic immunolocation of thrombospondin in human tissues.

  1985cited by this paper
• A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

  1983cited by this paper

• Differential responses to thrombospondin-1 and PDGF-BB in smooth muscle cells from atherosclerotic coronary arteries and internal thoracic arteries

  2024cites this paper
• Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus

  2023cites this paper
• Illuminating the potential causality of serum level of matrix metalloproteinases and the occurrence of cardiovascular and cerebrovascular diseases: a Mendelian randomization study

  2023cites this paper
• Blockade of CD47 function attenuates restenosis by promoting smooth muscle cell efferocytosis and inhibiting their migration and proliferation.

  2023cites this paper
• A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.

  2021cites this paper
• LMO7 Is a Negative Feedback Regulator of Transforming Growth Factor &bgr; Signaling and Fibrosis

  2019cites this paper
• Cross-talk of Leptin and Thrombospondin-1 in Atherosclerotic Complications

  2017cites this paper
• MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation

  2016cites this paper
• Molecular Ultrasound Imaging of &agr;v&bgr;3-Integrin Expression in Carotid Arteries of Pigs After Vessel Injury

  2016cites this paper
• Integrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis

  2016cites this paper
• Thrombospondin1 Deficiency Attenuates Obesity-Associated Microvascular Complications in ApoE-/- Mice

  2015cites this paper
• Under‐expression of α8 integrin aggravates experimental atherosclerosis

  2015cites this paper
• Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future

  2015cites this paper
• Off-target effects of glycoprotein IIb/IIIa receptor inhibitors.

  2014cites this paper
• Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans.

  2014cites this paper
• Ultraviolet light-irradiated collagen III modulates expression of cytoskeletal and surface adhesion molecules in rat aortic smooth muscle cells in vitro

  2014cites this paper
• Functional characterization of platelets in patients with arterial erectile dysfunction

  2014influential citation
• Impact of Moderate Blast Exposures on Thrombin Biomarkers Assessed by Calibrated Automated Thrombography in Rats

  2013cites this paper
• CTP Synthase 1, a Smooth Muscle–Sensitive Therapeutic Target for Effective Vascular Repair

  2013cites this paper
• Peroxisome proliferator-activated receptor gamma (PPARγ) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation

  2012cites this paper
• Engineering patterns to study vascular biology

  2012cites this paper
• Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces.

  2012cites this paper
• Higher Plasma Thrombospondin-1 Levels in Patients With Coronary Artery Disease and Diabetes Mellitus

  2012cites this paper
• Dysfunction of the endothelial‐platelet pathway in patients with erectile dysfunction before and after daily treatment with tadalafil

  2012cites this paper
• Different profile of endothelial cell apoptosis in patients with Klinefelter’s syndrome

  2012cites this paper
• Increased expression of endothelial-platelet dysfunctional pathway in patients with arterial erectile dysfunction.

  2011cites this paper
• Modulation of cell adhesion, proliferation and differentiation on materials designed for body implants.

  2011cites this paper
• Current issues with glycoprotein IIb-IIIa antagonists.

  2011cites this paper
• Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.

  2011cites this paper
• Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway.

  2010cites this paper
• Comparative Proteomics Profiling Reveals Role of Smooth Muscle Progenitors in Extracellular Matrix Production

  2010cites this paper
• Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling.

  2010cites this paper
• A Monoclonal Antibody Against αVβ3 Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs

  2010cites this paper
• Thrombospondin-4 Regulates Vascular Inflammation and Atherogenesis

  2010cites this paper
• Platelet GP IIIA polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece.

  2009cites this paper
• Der Einfluss von N-Cadherin auf die Migration glatter Gefäßmuskelzellen im Rahmen der Restenoseentstehung

  2008cites this paper
• The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities.

  2008cites this paper
• Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells

  2008cites this paper
• Counterbalancing forces: what is thrombospondin-1 doing in atherosclerotic lesions?

  2008cites this paper
• Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.

  2008cites this paper
• Rationale for intracoronary administration of abciximab

  2007cites this paper
• Activated alphavbeta3 integrin targeting in injury-induced vascular remodeling.

  2007cites this paper
• Involvement of ligand occupancy in Insulin‐like growth factor‐I (IGF‐I) induced cell growth in osteoblast like MC3T3‐E1 cells

  2007cites this paper
• Thrombospondins, their polymorphisms, and cardiovascular disease.

  2007cites this paper
• Glycosylation Mediates Up-regulation of a Potent Antiangiogenic and Proatherogenic Protein, Thrombospondin-1, by Glucose in Vascular Smooth Muscle Cells*

  2007cites this paper
• Endothelial Progenitor Thrombospondin-1 Mediates Diabetes-Induced Delay in Reendothelialization Following Arterial Injury

  2006cites this paper
• Effects of GP IIb/IIIa inhibitors on vascular inflammation, coronary microcirculation, and platelet function.

  2006cites this paper
• Angiotensin II stimulates endothelial integrin beta3 expression via nuclear factor-kappaB activation.

  2006cites this paper
• The pathobiology of the vessel wall: Implications for imaging

  2006cites this paper
• Identification of Sokotrasterol Sulfate As a Novel Proangiogenic Steroid

  2006cites this paper
• Identification of a TLR-Independent Pathway for Borrelia burgdorferi-Induced Expression of Matrix Metalloproteinases and Inflammatory Mediators through Binding to Integrin α3β11

  2006cites this paper
• Modulation of collagen turnover in cardiovascular disease.

  2005cites this paper
• Down but not out: new insights into the role of alphaVbeta3 integrins in vascular healing.

  2005cites this paper
• alpha8beta1 Integrin expression in the rat carotid artery: involvement in smooth muscle cell migration and neointima formation.

  2005cites this paper
• Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies.

  2005cites this paper
• Die Charakterisierung der differentiellen Genexpression invasiver und nicht-invasiver humaner glatter Gefäßmuskelzellen

  2005cites this paper
• Influence of beta3 integrin gene Leu/Pro33 polymorphism on primary glomerulonephritis.

  2005cites this paper
• Radiolabeled RGD uptake and alphav integrin expression is enhanced in ischemic murine hindlimbs.

  2005cites this paper
• Decreased Neurotrophin TrkB Receptor Expression Reduces Lesion Size in the Apolipoprotein E–Null Mutant Mouse

  2005cites this paper
• Regulation of vascular genes by glucose.

  2005cites this paper
• Genetic influences on blood pressure within the Stanislas Cohort

  2004cites this paper
• ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium.

  2004cites this paper
• Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation–fibrinolysis system

  2004cites this paper
• A Perspective on the Toxicological Mechanisms Possibly Contributing to the Failure of Oral Glycoprotein IIb/IIIa Antagonists in the Clinic

  2004cites this paper
• Coronary artery disease and the thrombospondin single nucleotide polymorphisms.

  2004cites this paper
• Development of glycoprotein IIb–IIIa antagonists: translation of pharmacodynamic effects into clinical benefit

  2004cites this paper
• β3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice

  2003cites this paper
• Thrombospondin-4 and Its Variants: Expression and Differential Effects on Endothelial Cells

  2003cites this paper
• No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction

  2003cites this paper
• Latent transforming growth factor-beta binding protein-1, a component of latent transforming growth factor-beta complex, accelerates the migration of aortic smooth muscle cells in diabetic rats through integrin-beta3.

  2003cites this paper
• Alphavbeta3-integrin antagonists inhibit thrombin-induced proliferation and focal adhesion formation in smooth muscle cells.

  2003cites this paper
• Regulation of gene expression in vascular cells by coagulation proteins.

  2003cites this paper
• Comparative Pharmacology of GP IIb/IIIa Antagonists

  2003cites this paper
• Increased Expression of Thrombospondin-1 in Vessel Wall of Diabetic Zucker Rat

  2003cites this paper
• De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen.

  2003cites this paper
• Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases.

  2003cites this paper
• DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection

  2003cites this paper
• Effects of thrombin on interactions between beta3-integrins and extracellular matrix in platelets and vascular cells.

  2003cites this paper
• Transfection of HEK 293 Cells , HASMCs , and Human Umbilical Vein Endothelial Cells

  2003cites this paper
• The role of platelet receptors and adhesion molecules in coronary artery disease.

  2003cites this paper
• Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein (cid:1) IIb (cid:2) 3 (GPIIb/IIIa) and (cid:1) v (cid:2) 3 Receptors Are Not Protected From Atherosclerosis

  2002cites this paper
• Thrombospondin-1 Mediates Smooth Muscle Cell Proliferation Induced by Interaction With Human Platelets

  2002cites this paper
• On the mechanism of thrombin-induced angiogenesis: involvement of alphavbeta3-integrin.

  2002cites this paper
• The role of alpha(v)beta3 integrins in vascular healing.

  2002cites this paper
• Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein αIIbβ3 (GPIIb/IIIa) and αvβ3 Receptors Are Not Protected From Atherosclerosis

  2002cites this paper
• Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation.

  2002cites this paper
• Decrease of vascular smooth muscle cell locomotion by abciximab, but not tirofiban: a possible role of different affinity to alpha v beta 3 integrins

  2002cites this paper
• Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis.

  2002cites this paper
• Regional differences in integrin expression: role of alpha(5)beta(1) in regulating smooth muscle cell functions.

  2001cites this paper
• The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis.

  2001cites this paper
• Pharmacological treatment for prevention of restenosis

  2001cites this paper
• &bgr;3-Integrin–Deficient Mice but Not P-Selectin–Deficient Mice Develop Intimal Hyperplasia After Vascular Injury: Correlation With Leukocyte Recruitment to Adherent Platelets 1 Hour After Injury

  2001cites this paper
• Eptifibatide and 7E3, but Not Tirofiban, Inhibit &agr;v&bgr;3 Integrin–Mediated Binding of Smooth Muscle Cells to Thrombospondin and Prothrombin

  2001cites this paper
• Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty.

  2001cites this paper
• [Pathophysiology of platelet activation and pharmacology of GPIIb/IIIa inhibitors].

  2001cites this paper
• Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant

  2001cites this paper
• Vascular Expression of Integrin-Associated Protein and Thrombospondin Increase After Mechanical Injury

  2001cites this paper
• Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3.

  2001cites this paper
• The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis.

  2001cites this paper
• Adhesion receptors of vascular smooth muscle cells and their functions.

  2001cites this paper